A Study of BL-B01D1 Combined With Glecirasib in Patients With KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (clinicaltrials.gov) - Sep 19, 2026 - P2 | N=36 | Not yet recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
New P2 trial • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
|